FRANKFURT (Reuters) -Swiss drugmaker Roche on Thursday lifted its full-year profit guidance, as cost cuts helped to offset ...

Eli Lilly and Company (NYSE:LLY) is one of the best long term low volatility stocks to buy right now. On October 17, J.P.

Eli Lilly was looking for infrastructure and an uncomplicated permit process for its $6.5M pharmaceutical manufacturing ...

Scientists have made significant progress in developing cancer therapies that help patients across cancer types. However, they face limitations in determining the results of drug effectiveness, as ...

The restaurant will be a sibling business of Aroma Experience, which opened in 2024 as part of the Carmel City Center ...

The signatures of President Vop Osili and several other councilors were missing from a letter released last week.

NEW YORK (Reuters) -Annual premiums for U. families with employer-sponsored health insurance in 2025 rose 6% to nearly $27,000, reflecting higher spending on popular weight-loss treatments and other ...

Some companies are pitching a new model for employers to help their workers pay for medications, but without using insurance.

The Trump administration is preparing a new probe into drug-pricing practices among U.S. trading partners, laying the ground ...

MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...

According to a filing with the Securities and Exchange Commission dated October 21, 2025, Generali Asset Management reduced ...

Chinese drugmaker Innovent Biologics could receive up to US$11.4 billion from a cancer-drug partnership with Japan's Takeda Pharmaceutical, marking the latest in a wave of tie-ups between Chinese ...